Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors.

Lohmann S, Brix T, Varghese J, Warneke N, Schwake M, Suero Molina E, Holling M, Stummer W, Schipmann S.

J Neurosurg. 2020 Mar 20:1-11. doi: 10.3171/2020.1.JNS193186. [Epub ahead of print]

PMID:
32197255
2.

Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study.

Suero Molina E, Stögbauer L, Jeibmann A, Warneke N, Stummer W.

Acta Neurochir (Wien). 2020 Apr;162(4):785-793. doi: 10.1007/s00701-020-04227-7. Epub 2020 Feb 7.

3.

Comparison of stand-alone cage and cage-with-plate for monosegmental cervical fusion and impact of virtual reality in evaluating surgical results.

Zawy Alsofy S, Nakamura M, Ewelt C, Kafchitsas K, Fortmann T, Schipmann S, Suero Molina E, Welzel Saravia H, Stroop R.

Clin Neurol Neurosurg. 2020 Apr;191:105685. doi: 10.1016/j.clineuro.2020.105685. Epub 2020 Jan 20.

PMID:
32000041
4.

Letter to the Editor. Sodium fluorescein versus 5-aminolevulinic acid to visualize high-grade gliomas.

Suero Molina E, Brokinkel B.

J Neurosurg. 2020 Jan 24:1-3. doi: 10.3171/2019.12.JNS193180. [Epub ahead of print] No abstract available.

PMID:
31978890
5.

Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.

Schipmann S, Müther M, Stögbauer L, Zimmer S, Brokinkel B, Holling M, Grauer O, Suero Molina E, Warneke N, Stummer W.

J Neurosurg. 2020 Jan 24:1-11. doi: 10.3171/2019.11.JNS192443. [Epub ahead of print]

PMID:
31978877
6.

The rise of quality indicators in neurosurgery: 30-day unplanned reoperation rate evaluated in 3760 patients-a single-center experience.

Suero Molina E, Schildmacher C, Doods J, Freistühler M, Hellwig SJ, Stummer W, Schipmann S.

Acta Neurochir (Wien). 2020 Jan;162(1):147-156. doi: 10.1007/s00701-019-04146-2. Epub 2019 Dec 4.

PMID:
31802277
7.

Markers for Identifying and Targeting Glioblastoma Cells during Surgery.

Schipmann S, Schwake M, Suero Molina E, Stummer W.

J Neurol Surg A Cent Eur Neurosurg. 2019 Nov;80(6):475-487. doi: 10.1055/s-0039-1692976. Epub 2019 Aug 29. Review.

PMID:
31466109
8.

Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.

Schwake M, Kaneko S, Suero Molina E, Müther M, Schipmann S, Köchling M, Brentrup A, Stummer W.

Acta Neurochir (Wien). 2019 Oct;161(10):2099-2105. doi: 10.1007/s00701-019-04039-4. Epub 2019 Aug 21.

PMID:
31435824
9.

Intraoperative fluorescence diagnosis in the brain: a systematic review and suggestions for future standards on reporting diagnostic accuracy and clinical utility.

Stummer W, Koch R, Valle RD, Roberts DW, Sanai N, Kalkanis S, Hadjipanayis CG, Suero Molina E.

Acta Neurochir (Wien). 2019 Oct;161(10):2083-2098. doi: 10.1007/s00701-019-04007-y. Epub 2019 Jul 30. Review.

10.

Optimizing 5-ALA Induced Fluorescence Visualization: Comment Regarding Recent Article on Fluorescence-Based Real-Time Kinetics Protoporphyrin-IX Measurements Article in Neurosurgery.

Suero Molina E, Kaneko S, Stummer W.

World Neurosurg. 2019 Aug;128:391-392. doi: 10.1016/j.wneu.2019.05.161. Epub 2019 May 24. No abstract available.

PMID:
31132500
11.

Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas.

Kaneko S, Suero Molina E, Ewelt C, Warneke N, Stummer W.

Neurosurgery. 2019 Oct 1;85(4):E739-E746. doi: 10.1093/neuros/nyz129.

PMID:
31058995
12.

Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note.

Suero Molina E, Ewelt C, Warneke N, Schwake M, Müther M, Schipmann S, Stummer W.

J Neurosurg. 2019 Apr 26:1-7. doi: 10.3171/2018.12.JNS182422. [Epub ahead of print]

PMID:
31026838
13.

Establishing risk-adjusted quality indicators in surgery using administrative data-an example from neurosurgery.

Schipmann S, Varghese J, Brix T, Schwake M, Keurhorst D, Lohmann S, Suero Molina E, Mauer UM, Dugas M, Warneke N, Stummer W.

Acta Neurochir (Wien). 2019 Jun;161(6):1057-1065. doi: 10.1007/s00701-018-03792-2. Epub 2019 Apr 26.

PMID:
31025177
14.

Clinical Vasospasm After an Extended Endoscopic Endonasal Approach for Recurrent Pituitary Adenoma: Illustrative Case and Systematic Review of the Literature.

Suero Molina E, Di Somma A, Stummer W, Briganti F, Cavallo LM.

World Neurosurg. 2019 Aug;128:29-36. doi: 10.1016/j.wneu.2019.04.046. Epub 2019 Apr 16.

PMID:
31003025
15.

Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments.

Reulen HJ, Suero Molina E, Zeidler R, Gildehaus FJ, Böning G, Gosewisch A, Stummer W.

Acta Neurochir (Wien). 2019 Jun;161(6):1109-1124. doi: 10.1007/s00701-019-03882-9. Epub 2019 Apr 12. Review.

PMID:
30980242
16.

Surgical Adjuncts to Increase the Extent of Resection: Intraoperative MRI, Fluorescence, and Raman Histology.

Hollon T, Stummer W, Orringer D, Suero Molina E.

Neurosurg Clin N Am. 2019 Jan;30(1):65-74. doi: 10.1016/j.nec.2018.08.012. Review.

PMID:
30470406
17.

Local Tumor Control and Clinical Symptoms After Gamma Knife Radiosurgery for Residual and Recurrent Vestibular Schwannomas.

Suero Molina E, van Eck ATCJ, Sauerland C, Schipmann S, Horstmann G, Stummer W, Brokinkel B.

World Neurosurg. 2019 Feb;122:e1240-e1246. doi: 10.1016/j.wneu.2018.11.022. Epub 2018 Nov 14.

PMID:
30447443
18.

The difficulty of predicting clinical outcome after intended submaximal resection of large vestibular Schwannomas.

MacKenzie R, Sporns P, Zoubi T, Koopmann M, Ewelt C, Stummer W, Brokinkel B, Suero Molina E.

J Clin Neurosci. 2018 Apr;50:62-68. doi: 10.1016/j.jocn.2018.01.033. Epub 2018 Feb 21.

PMID:
29429787
19.

Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.

Suero Molina E, Schipmann S, Mueller I, Wölfer J, Ewelt C, Maas M, Brokinkel B, Stummer W.

J Neurosurg. 2018 Nov 1;129(5):1223-1230. doi: 10.3171/2017.7.JNS171312.

PMID:
29328000
20.

Where and When to Cut? Fluorescein Guidance for Brain Stem and Spinal Cord Tumor Surgery-Technical Note.

Suero Molina E, Stummer W.

Oper Neurosurg (Hagerstown). 2018 Sep 1;15(3):325-331. doi: 10.1093/ons/opx269.

21.

Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients.

Schipmann S, Suero Molina E, Frasch A, Stummer W, Wiewrodt D.

J Neurooncol. 2018 Feb;136(3):505-514. doi: 10.1007/s11060-017-2670-y. Epub 2017 Nov 17.

PMID:
29147859
22.

Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.

Suero Molina E, Schipmann S, Stummer W.

Neurosurg Rev. 2019 Jun;42(2):197-208. doi: 10.1007/s10143-017-0907-z. Epub 2017 Sep 18. Review.

23.

Fluorescence Imaging/Agents in Tumor Resection.

Stummer W, Suero Molina E.

Neurosurg Clin N Am. 2017 Oct;28(4):569-583. doi: 10.1016/j.nec.2017.05.009. Epub 2017 Aug 18. Review.

24.

The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?

Voß KM, Spille DC, Sauerland C, Suero Molina E, Brokinkel C, Paulus W, Stummer W, Holling M, Jeibmann A, Brokinkel B.

J Neurooncol. 2017 Jul;133(3):641-651. doi: 10.1007/s11060-017-2481-1. Epub 2017 May 19.

PMID:
28527009
25.

Quality Indicators in Cranial Neurosurgery: Which Are Presently Substantiated? A Systematic Review.

Schipmann S, Schwake M, Suero Molina E, Roeder N, Steudel WI, Warneke N, Stummer W.

World Neurosurg. 2017 Aug;104:104-112. doi: 10.1016/j.wneu.2017.03.111. Epub 2017 Apr 30. Review.

PMID:
28465269
26.

Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.

Suero Molina E, Wölfer J, Ewelt C, Ehrhardt A, Brokinkel B, Stummer W.

J Neurosurg. 2018 Feb;128(2):399-405. doi: 10.3171/2016.11.JNS161072. Epub 2017 Mar 24.

PMID:
28338432
27.

When the Infection Hits the Wound: Matched Case-Control Study in a Neurosurgical Patient Collective Including Systematic Literature Review and Risk Factors Analysis.

Schipmann S, Akalin E, Doods J, Ewelt C, Stummer W, Suero Molina E.

World Neurosurg. 2016 Nov;95:178-189. doi: 10.1016/j.wneu.2016.07.093. Epub 2016 Aug 6. Review.

PMID:
27506410
28.

Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgery.

Schwake M, Stummer W, Suero Molina EJ, Wölfer J.

Acta Neurochir (Wien). 2015 May;157(5):877-9. doi: 10.1007/s00701-015-2401-0. Epub 2015 Mar 28. No abstract available.

29.

Cerebrospinal fluid leakage in Gorham-Stout disease due to dura mater involvement after progression of an osteolytic lesion in the thoracic spine.

Suero Molina EJ, Niederstadt T, Ruland V, Kayser G, Stummer W, Ewelt C, Rössler J.

J Neurosurg Spine. 2014 Dec;21(6):956-60. doi: 10.3171/2014.8.SPINE131064. Epub 2014 Oct 17. Review.

PMID:
25325172
30.

Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluation.

Schroeteler J, Reeker R, Suero Molina E, Brokinkel B, Holling M, Grauer OM, Senner V, Stummer W, Ewelt C.

Eur Surg Res. 2014;53(1-4):37-42. doi: 10.1159/000364943. Epub 2014 Jul 18.

PMID:
25059972
31.

Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence.

Suero Molina EJ, Ardon H, Schroeteler J, Klingenhöfer M, Holling M, Wölfer J, Fischer B, Stummer W, Ewelt C.

Clin Neurol Neurosurg. 2013 Oct;115(10):2075-81. doi: 10.1016/j.clineuro.2013.07.016. Epub 2013 Jul 31.

PMID:
23915916

Supplemental Content

Loading ...
Support Center